RESPONSES AT EARLY LANDMARK TIME POINTS ARE ASSOCIATED WITH OUTCOMES IN HEAVILY PRETREATED CP-CML PATIENTS (PTS) TREATED WITH PONATINIBM. Mueller,M. Baccarani,M. W. Deininger,F. Guilhot,A. Hochhaus,T. P. Hughes,N. P. Shah,M. Talpaz,S. Lustgarten,V. M. Rivera,T. Clackson,F. G. Haluska,J. E. CortesHAEMATOLOGICA(2015)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要